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Abstract.  SEC14p is required for protein transport 
from the yeast Golgi complex. We describe a quantita- 
tive analysis of yeast bulk membrane and Golgi mem- 
brane phospholipid composition under conditions 
where Golgi secretory function has been uncoupled 
from its usual SEC14p requirement.  The data demon- 
strate that SEC14p specifically functions to maintain  a 
reduced phosphatidylcholine content in Golgi mem- 
branes and indicate that overproduction of SEC14p 
markedly reduces the apparent rate of phosphatidyl- 
choline biosynthesis via the CDP-choline pathway in 
vivo. We suggest that SEC14p serves as a sensor of 
Golgi membrane phospholipid composition through 
which the activity of the CDP-choline pathway in 
Golgi membranes is regulated such that a phos- 
phatidylcholine content that is compatible with the 
essential secretory function of these membranes is 
maintained. 
T 
HE  Saccharomyces  cerevisiae  SEC14 gene  product 
(SEC14p) is a phosphatidylinositol/phosphatidylcho- 
line  transfer  protein whose function is essential  for 
both protein transport from a late yeast Golgi compartment 
and for yeast viability (Bankaitis  et al.,  1989, 1990; Fran- 
zusoff and Schekman,  1989; Aitken et al.,  1990). As such, 
SEC14p has provided a system with which to study the in 
vivo function of a ubiquitous class of enigmatic proteins,  the 
phospholipid transfer proteins,  that are operationally defined 
by their ability to serve as diffusible carders of phospholipid 
monomers between membrane bilayers in vitro (reviewed by 
Rueckert and Schmidt,  1990;  Wirtz,  1991; Cleves et ai., 
1991a). We consider SEC14p to play a direct role in yeast 
Golgi secretory function as this protein is found in both a cy- 
toplasmic pool and in a stable,  and apparently  specific, pe- 
ripheral association with the yeast Golgi complex (Bankaitis 
et al.,  1989; Cleves et al.,  1991b). 
To date, the most instructive clues relating to SECI4p func- 
tion in vivo have been obtained from analyzes of yeast mu- 
tants that no longer require SEC14p in order to survive and 
efficiently execute  Golgi secretory function  (Cleves et al., 
1989, 1991b). These studies revealed that one unanticipated 
mechanism  for bypass of SEC14p  function involves inac- 
tivation of the cytosine-diphosphate (CDP)-choline pathway 
for phosphatidylcholine (PC) ~ biosynthesis,  a pathway that 
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consists  of three reactions  resulting  in the incorporation of 
choline into PC (Kennedy and Weiss,  1956; see Fig.  1 A). 
The finding that the cellular requirement for SEC14p is ob- 
viated by inactivation of a specific avenue for PC biosynthe- 
sis demonstrated, for the first time, a direct physiological re- 
lationship  between an  in  vitro  ligand  of a  phospholipid 
transfer protein and the function of that phospholipid transfer 
protein in vivo. The collective SEC14p data,  including  the 
data  indicating  that  SEC14p  prefers  phosphatidylinositol 
(PI) over PC as a substrate in the in vitro transfer  reaction 
(Daurn and Paltauf,  1984), have been reconciled in the PI/ 
PC hypothesis  for SEC14p function  in vivo (Cleves et al., 
1991a,b). The PI/PC hypothesis proposes that SEC14p func- 
tions  to maintain  an appropriately elevated  PI/PC ratio in 
Golgi membranes,  a ratio that  is  somehow critical  to the 
secretory competence of these membranes (Fig.  1 B). The 
central  questions  to be addressed include:  (a) what is the 
functional  basis for the unanticipated  relationship  between 
PC synthesis via the CDP-choline pathway and the cellular 
requirement for SEC14p function;  (b) does SEC14p in fact 
regulate the PI/PC ratio of yeast Golgi membranes in vivo; 
and (c) does this control involve SEC14p-dependent  changes 
in Golgi PI levels, Golgi PC levels, or both (Bankaitis et al., 
1990; Cleves et al.,  1991a). Moreover,  any comprehensive 
model for SEC14p function  in vivo must also take into ac- 
count three puzzling  features of the suppression of SEC14p 
dysfunction by inactivation of the CDP-choline pathway (re- 
viewed in Cleves et al., 1991b; McGee et al., 1992). The first 
concerns the finding that, while elimination  of the contribu- 
tion of the CDP-choline pathway to net PC biosynthesis in 
yeast (i.e., by depriving cells of exogenous choline)  fails to 
bypass the cellular requirement for SEC14p,  disruption of 
the  CDP-choline  pathway  nonetheless  effects  bypass  of 
© The Rockefeller University Press, 0021-9525/94/02/273/15 $2.00 
The Journal of Cell Biology, Volume 124, Number 3, February 1994 273-287  273 SEC14p in choline-free medium. The second relates to the 
question of why disruption of the snd,2-diacylglycerol cho- 
linephosphotransferase structural gene (C/T/) effects a by- 
pass of the SEC14p requirement whereas disruption of the 
sn-l,2-diacylglycerol  ethanolamine-phosphotransferase struc- 
tural gene (EPT/) does not (Cleves et al., 1991b). These en- 
zymes  are homologous  aminoalcohol-phosphotransferases 
and both can efficiently catalyze the ultimate PC biosynthetic 
reaction of  the CDP-choline pathway in vitro (Hjelmstad and 
Bell, 1987, 1988). The third feature is the finding that genetic 
disruption of the PE methylation pathway for PC biosynthesis 
(see Fig.  1 A) is irrelevant to the cellular requirement for 
SEC14p. 
In this report, we describe the measurement of yeast Golgi 
membrane  phospholipid  composition  as  a  function  of 
SECl4p  activity.  We  demonstrate  that,  under  conditions 
where Golgi secretory function has been uncoupled from the 
SEC14p requirement, SECI4p dysfunction results in a dra- 
marie increase in the PC content of Golgi membranes with- 
out measurable changes in Golgi PI levels. Double-mutant 
analyses indicate that the increase in Golgi PC measured un- 
der such conditions is accounted for by CDP-choline path- 
way activity. We also demonstrate that CDP-eholine path- 
way  function  is  required  for  the  maintenance  of normal 
phosphatidyleboline biosynthetic  rates  in  bulk yeast  cell 
membranes, and that this requirement is independent of the 
presence or absence of choline in the growth medium.  Fi- 
nally, we present evidence that overproduction of SECI4p 
results in a specific reduction in bulk PC biosynthesis via the 
CDP-eholine pathway, but not via the PE methylation path- 
way. On the basis of these collective data, we conclude that 
the essential cellular function of SECI4p isto maintain a re- 
duced PC content in yeast Golgi membranes and suggest an 
alternative proposal for how SEC14p executes this in vivo 
function  in  a  manner  that  does  not  invoke  phosphollpid 
transfer per se. We suggest the possibility that SECI4p may 
serve as a dynamic sensor of the relative PI and PC content 
in Golgi membranes through which the local activity of the 
CDP-eholine  biosynthetic pathway  in  yeast  Golgi  mem- 
branes is regulated, so that an acceptable PC content can be 
maintained. 
Materials and Methods 
Yeast Strains, Media, and Reagents 
The genotypes of the yeast strains used in this study are provided in Table 
L Yeast complex medium (YP), YP supplemented with glucose to a final 
concentration  of  2 % (YPD), and synthetic  complete  media have  been previ- 
ously described by Sherman et ai. (1983) and Klig et al. (1985), respec- 
tively, myo-Inusitol  and choline chloride were purchased from Sigma Im- 
munochemicals (St. Louis, MO) and were used to supplement synthetic 
defined media to final concentrations of I mM each as indicated. [32p]Or- 
thophosphate (carrier-free) and [14C]choline  chloride (40-60 mCi/mmol) 
were obtained from New England Nuclear (Boston, MA). [14C]Choline 
chloride (55 mCi/mmol) and L-[methyl-t4C]methionine (55 mCi/mmol) 
were obtained from American Rndiolabeled Chemicals, Inc. (St. Louis, 
MO). Silica-impregnated  SG81 chromatography  paper and rhodamine 6(3 
were from Whatman Laboratory Products (Clifton, NJ) and Sigma Im- 
munochamicels, respectively.  The remaining reagents and routine genetic 
techniques used were described by Cleves et ai. (1991b). 
Determination of Bulk 
Phospholipid Content by Radiolabeling 
with l~P]Orthophosphate 
Pulse labeling of the appropriate yeast strains was performed on cultures 
grown to mid-logarithmic growth phase (OD~o  ffi 0.8) in the ~2n~fic 
complete medium of Klig et  aL  (1985) and  incubated with  [3 P]or- 
thophospbate (32pi; 10 /zCi/ml) for 30 min at 250C with shaking. For 
steAuly-state 32pi-labe]ing e.xperiments,  yeast were grown in synthetic com- 
plete medium overni~,ht  then subeultured into the same fresh medium. The 
cultures were then presented with 32pi (10 ~tCi/ml) and incubated at 25°C 
with sbakin~ for five to six cell generations, a sufficiently  long period of 
incorporation of 32pi to insure steady-state  labeling of cellular pbospholip- 
ids (Atkinsun  et al., 1980; Kiig et al., 1985). For  both types of  radiolabeling 
experiments, phospholipids were extracted by the method of Atkinson 
(1984). Yeast ceils were pelleted by a low-speed spin (500 8) in a clinical 
centrifuge, washed  by incubation  in ice cold ~  (5 %) for 20 rain with sub- 
sequent repelledng, and the cell pellet was re.suspended  in 1 ml polar  extrac- 
tion solvent (Steiner and I.ester, 1972) with healing at 65°C for 20 rain. 
Phuspholipids were recovered from the ceil suspension by the addition of 
5.0 ml CHC13/CHsOH/butylated hydroxytoluene (BI-rr) (2:1:0,0005%), 
followed  by incubation at 4oc for 2-6 h. The extraction cocktails were sub- 
seqnently  centrifuged  at 500 g for 5 rain to separate the organic and aqueous 
phases. The organic phase was removed, dried under N2 gas, and resns- 
pended in 60 #l CHCI3/CH3OH/BHT. Radiolabeled phosphofipids were 
subsequently  resolved  by two-dimensional  chromatography  using Whatman 
SG81 paper treated as described by Steiner and Lester (1972). First dimen- 
sion solvent was CHCh/CH3OH/NH4OH/H20 (22:9:1:0.26) and second 
dimension solvent was CHCI3/CH3OI'I/CH3COOH/H20 (8:1:1.25:0.25). 
Finally, radiolabeled phospholipida were visualized by autoradiography, 
identified by comparison to commercial phospbolipid standards, and de- 
fined phospholipid species were recovered  by excision from the chromatog- 
raphy paper. Quantitation of individual phospholipid species was achieved 
by scintillation counting. 
In experiments where phospholipid composition was determined as a 
function of viable cell number, parailel cultures were initiated from the 
same starter culture and were co-incubated. One culture received radiolabel 
for the appropriate period of time and was reserved for phospbolipid analy- 
sis, whereas the other culture did not receive radiolabel and was reserved 
for determination  of viable cell number. The culture reserved for viable cell 
counting was quick-chilled  in an ice-water  hath, appropriately diluted, and 
stained with 4 mg/ml Phloxine B to ~  between viable (unstained) 
and nonviable (red-staining) ceils. Viable ceils were counted with the aid 
of a bemacytometer (Hausser Scientific, Boulder, CO). BudMin~ cells in 
which the daughter ceils were judged to be less than half the size of the pa- 
rental ceil were recorded as single cells, whereas budding ceils in which 
the buds were  judged to exceed  half the size of  the mother ceil were counted 
as two ceils. The timing of the chilling of the culture reserved for viable 
ceil counting coincided with the extraction of pbospholipid from the radio- 
labeled culture. Glycerophospholipids  were extracted from the radiolabeled 
culture and analyzed as described above. 
F*C]Choline Labeling of Yeast l.,ipids 
The appropriate yeast strains were grown to mid-logarithmic  growth phase 
in defined medium lacking choline, and presented with [14C]choline  chlo- 
ride (1/~Ci/ml)  for 30 rain at 250C with sbAki~. Incorporation of label was 
measured by removing  one-tenth of the culture, immobilization  of the cul- 
ture aliquot on 0.5 ~,m glass fiber filters, washing of the filters 4× with 2.5 
vol of 10 mM choline per wash, and re.snspension  of the dried cell pellets 
and filters to which these were immobilized in scintillation fluid for count- 
ing. [14C]Chollne  incorporation values were used to normalize loading of 
lipid samples  derived from each of these cultures for chromatographic  anal- 
ysis. Phuspbofipids  were extracted from the remainder of each culture, as 
described above, and normaliTed  amounts of  lipid sample from each culture 
were loaded onto Whatman SG81 paper for resolution by chromatography 
in  one  dimension using  a  solvent system of CHCI3/CH3OH/NIhOH 
(22:5.7:1). [14C]Choline-cuntaining  lipids were visualized by autoradiogra- 
play using Kodak X-OMAT AR film. 
In tim6 course studies, the appropriate yeast strains were grown to mid- 
logarithmic growth phase in defined medium lacking choline, concentrated 
to 20D~oo U/ml, and allowed to incorporate [t4C]choline chloride (1 
/zCi/ml) into phospholipid at 250C in a 1 ml culture volume as a function 
of time. Incorporation of label into cells was measured by removing one- 
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Strain  Genotype  Origin 
CTY182  MATa,  ura3-52,  Ahis3-200,  lys2-801  Bankaitis et ai.  (1989) 
CTYI-IA  MAT a, ura3-52, Ahis3-200,  1ys2-801, sec14-1 ~  Bankaitis et al.  (1989) 
CTY10  MAT c~, ade2-101, sec14-1 ts, sac1-16  ~  This study 
CTY31  MAT a, ade2-101,  sec14-1%  bsd2-1  This study 
CTY105  MAT a, ura3-52,  Ahis3-200,  lys2-801, sec14-1%  bsr2-5  This study 
CTYI24  MAT a, ura3-52, Ahis3-200,  lys2-801,  sec14-1%  bsd1-124  Cleves et al.  (1991) 
CTY156  MAT a, ura3-52,  Ahis3-200,  ade2-101,  1ys2-801, sec14-1'L  bsr3-2  This study 
CTY234  MAT a,  ura3-52, Ahis3-200,  Iys2-801/YEp(KEX2)  Whitters et al.  (1993) 
CTY392  MAT a, ura3-52, Ahis3-200,  1ys2-801, sec14-1%  cki-284::HIS3  This study 
CTY434  MAT a, ura3-52,  his4-519, ade2-101,  leu2-3,  112, sec14-1 's, cptl::LEU2  This study 
CTY479  MAT c~, ura3-52,  Ahis3-200, ade2-101,  bsd2-1  This study 
CTY521  MAT c~, ura3,  Ahis3,  lys2,  trpl, leu2/YEp(SEC14)  This study 
CTY525  MAT c~, ura3, Ahis3,  lys2,  trpl,  leu2/YEp(lac112)  This study 
tenth of the culture, harvesting the cells in that culture aliquot by rapid filtra- 
tion onto 0.5-#m glass fiber filters,  washing of the filters 4×  with 50 vol 
of 10 mM choline per wash, and resuspension of the dried filters in scintilla- 
tion fluid  for counting.  Phospholipids were  extracted,  resolved,  and vi- 
sualized  from the  remainder of each culture,  as  described above,  and 
[14C]choline-labeled phospholipids quantitated by scintillation  counting. 
OrganeUe Marker Assays 
Endoplasmic reticulum,  mitochondrial membrane, and plasma membrane 
markers were NADPH cytochrome c reductase,  cytochrome c oxidase, and 
vanadate-sensitive  ATPase,  respectively,  and these enzymatic activities 
were assayed by established methods (Kreibich et al.,  1973; Mason et al., 
1973;  Bowman and Siayman,  1979).  Vacuolar, mitochondrial and Golgi 
membrane markers were dipeptidylaminopeptidase  B, Fi-ATPase  B sub- 
unit and KEX2p,  respectively,  and these markers  were  quantitated by 
ELISA as described by Cleves et al. (1991b). Antibody concentrations for 
these ELISA  measurements were  10.2/zg/ml, 6.7/zg/ml, and 3.4/~g/rrd, 
respectively.  The dipeptidylaminnpeptidase B, Fi-ATPase  B subunit, and 
KEX2p  antibodies  were  from  polyclonal  rabbit  antisera  generously 
provided by Tom Stevens (University of Oregon,  Eugene, OR), David Bed- 
well (University  of Alabama at Birmingham, Birmingham, AL), and Robert 
Fuller (Stanford  University,  Stanford,  CA),  respectively. 
Preparation of  Polyclonal Mouse anti-GMP Antibody 
Golgi membranes from the most highly enriched Golgi fractions (see below 
for preparative details) were diluted threefold  in 10 mM triethanolamine 
buffer, pH 7.2, supplemented with protease inhibitors (Cleves et al., 1991b). 
The membranes were then pelleted onto a 4.3 M sorbitol cushion by cen- 
trifugation at 250,000 g for 3 h in an ultracentrifuge (TLS-100; Beckman 
Instruments,  Palo  Alto,  CA).  Pelleted  membranes  were  collected, 
resuspended in an equal volume of 200 mM Na2CO3, pH  11.5, and in- 
cubated on ice for 60 rain. The membranes were subsequently  repelletad 
at 250,000  g as before,  re-extracted in 1.5 ml of fresh 100 mM Na2CO3, 
pH 11.5, by incubation on ice for 60 rain, and repelleted.  Finally, the ex- 
tracted membranes were solubilized in 0.1% Triton X-100 and the integral 
membrane protein concentration was determined using the bicinchoninic 
acid (BCA) protein assay kit marketed by Pierce Chemical Co. The solubi- 
lized integral membrane proteins were subsequently  emulsified in an equal 
volume of Freund's incomplete adjuvant and injected i.p. into Balb/C mice 
(125/zg/injection).  A serial 3-wk injection schedule was followed, and the 
antibody response was monitored by immunnblot analysis. Serum lipopro- 
teins were cleared from immune serum by precipitation with CaCI2 and 
dextran sulfate before use. 
Indirect Immunofluorescence Methods 
Crude polyclonal  anti-GMP antisera was affinity purified using a GMP- 
Sepharose affinity column that was prepared using a modification of an es- 
tablished procedure (Skinner et al.,  1993).  Briefly, Golgi integral mem- 
brane proteins (prepared by carbonate extraction of Golgi membranes; see 
above) were solubilized in 0.1% SDS, 0.1 M NaHCO3, pH 8.3, 0.5 M NaCI 
(binding buffer), incubated overnight at 4°C with agitation, and clarified by 
centrifugation at 10,000 g. Cyanogen bromide activated Sepbarose,  washed 
with I mM HC1, was added to the clarified GMPs at a final protein concen- 
tration of 3.4 mg/ml matrix. The Sepharose slurry was incubated overnight 
at 4°C with constant mixing. The matrix was subsequently incubated with 
0.1% SDS, 0.2 M glycine, pH 8.0, for 2 h at 4"C, and then alternately washed 
for  three  separate  rounds  with  binding buffer  and 0.1% SDS,  0.1  M 
NaC2H302, pH 4.0. The matrix was mock eluted with 0.1% SDS, 0.1 M 
glycine,  pH 2.8, 0.5 M NaC1 (elution buffer) before equilibration in PBS 
(0.1% SDS).  The efficiency of conjugation  of GMPs to the matrix was 
judged to be 96.2%.  Anti-GMP polyclonai  antibodies were precipitated 
with ammonium sulfate, dialyzed against equilibration buffer and recycled 
over 2 ml of the GMP-Sepharose  matrix at 4°C.  After extensive  washing 
with equilibration buffer, adsorbed antibodies were eluted in 0.5-ml frac- 
tions with 0.1% SDS, 0.I  M glycine, pH 2.8,  150 mM NaC1, and adjusted 
to pH 7.0 with 1 M Tris, pH 8.8. Affinity-purifiad antisera were pooled, con- 
centrated, and assayed  for protein content. Antisera was  quantitated in 
ELISA as described using 0.7 #g/ml final antibody concentration (Cleves 
et al.,  1991b). Immunofluorescent  colocalization  was performed as preci- 
ously described (Cleves  et al.,  1991b) with the following  modifications. 
Briefly, formaldehyde fixed spheroplasts  expressing KEX2 on a multicopy 
plasmid were deposited onto coverslips by a 5-rain centrifugation at 1,000 g 
in a Cytospin 2 centrifuge (Cytospin 2; Shandon Inc., Sewickley, PA). Cells 
were subsequently  immobilized on the cover slips by a 6-rain incubation in 
ice-cold  methanol, permeabilized by a 30-60-s rinse in ice-cold  acetone, 
treated with 1% BSA in PBS (blocking  buffer),  and incubated with rabbit 
anti-KEX2p and mouse anti-GMP antibodies in blocking buffer containing 
0.05% Tween 20 at concentrations of 13 and 23/~g/rnl, respectively. Sphero- 
plasts were washed extensively  in blocking buffer and subsequently  incu- 
bated with FITC-conjugated  goat anti-rabbit and Texas red-conjugatad goat 
anti-mouse antibodies (Jackson ImmunoResearch Labs., Inc., West Grove, 
PA) for 2 h at a concentration of 30/zg/rnl each.  After extensive washing 
in blocking buffer, cells were visualized  on a Zeiss Axioplan microscope 
equipped for fluorescence with UV filters and an I-IBO 50-W mercury lamp. 
Determination of Golgi Membrane 
Phospholipid Content 
Purified Golgi membranes were prepared from the appropriate yeast cul- 
tures (1 liter) by two successive  equilibrium sorbitol gradient centrifuga- 
tions of the 100,000 g pellet fraction (P100) essentially  as described by 
Cleves et al. (1991b) with the modification that a self-forming 30-80% equi- 
librium gradient was used to provide an initial fractionation of the P100. 
Cultures were grown to mid-logarithmic growth phase in YPD at 25°C, and 
shifted to YP (0.1% glucose medium) for an additional 3 h. Cells were then 
poisoned by the sequential  addition of cycloheximide  and NAN3, and fur- 
ther fractionated exactly as previously described (Cleves et al., 1991b). Cul- 
tures challenged with a temperature shift to 37*C were transferred to a 
prewarmed  water bath 75 rain before cyclobeximide  and NaN3 addition. 
This period of temperature shift was more than sufficient to impose the 
secl4-1  ts defect,  a defect that is rapidly manifested upon temperature shift 
to 37*C (Bankaitis et al., 1989). Golgi membranes prepared by this proce- 
dure were routinely enriched some 185-200-fold over crude lysate. In eases 
where the secl4-1  ts secretory block was imposed in otherwise wild-type 
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crude lysate (data not shown). 
Phospholipids were extracted from purified Golgi fractions by organic 
extraction using 5 ml of CHCla/CH3OH/BHT (2:1:0.0005  %). After gentle 
eentrifugation to separate aqueous and organic phases, the organic phase 
was collected and washed 3x with  2 rni of 10% methanol per wash to re- 
move the excess sorbitol left over from the equilibrium gradients. The 
washed organic phase was subsequently dried under N2 gas, resuspended 
in 60  /d of CHC13/CH3OHIBHT (2:1:0.0005%), and resolved by two- 
dimensional Whatrnan SG81 paper chromatography. First dimension sol- 
vent was CHC131CH3OH/NI-I4OH/H20  (22:9:1:0.26) and second dimen- 
sion  solvent was  CHCIalCH3OHICH3COOHIH20 (8:1:1.25:0.25). Re- 
solved lipids were stained with a 0.0012% solution of rhodamine 6(3 and 
visualized by illumination under UV light (Christie, 1987). The individual 
phospholipid spots were excised, the  pbospholipids eluted  in  CHCI3/ 
CH3OH/BHT (2:1:0.0005  %), the phospholipid einates dried under gentle 
vacuum with heat (65"C), and phospholipid  content was quantitated by as- 
say for total phosphorus by the method of Ames (1966). 
For determination of the total Golgi glycerophospholipid  content as a 
function of Golgi protein, Golgi fractions were purified from the appropri- 
ate yeast strains by the method described by Cleves et al. (1991b), and an 
aliquot of the purified Golgi fraction was used to determine protein by the 
BCA assay (see above). The washed  organic  extract of  the remaining  portion 
of the Golgi fractions was dried under gentle vacuum with heating (65"C), 
and total Golgi glycerophospholipid  was qnantitated by assay for phospho- 
rus in the unresolved Goigi glycerophospholipid  fraction by the method of 
Ames (1966). 
Radiolabeling of  Phospholipids 
with [methyl-uC]Methionine 
Pulse labeling of the appropriate yeast strains was performed on cultures 
grown to mid-logarithmic growth phase (ODtoo =  0.8) in the synthetic 
medium of Klig et al. (1985) and incubated with L-[methy/-14C]methionine 
(1 #Ci/ml) for 30 rain at 25"C with shaking. A small amount of unlabeled 
methionine was added to the culture simultaneously with the radiolabel to 
a final concentration  of  7.5/~g/ml. Incorporation  of  label into cells was mea- 
sured by removing  one-tenth  of  the culture, collection of  cells from that cul- 
ture aliquot onto 0.5/xM glass fiber filters, washing of the filters 4x with 
50 vol of  water  per wash, and resuspension  of  the dried filters  in scintillation 
fluid for counting. Phospholipids were extracted from the remainder of the 
culture as described above. The [methy/-14C]methionine-labeled  phospho- 
lipids were resolved by one-dimensional  paper chromatography on What- 
man SG81 paper treated as described above with CHC13/CH3OH/NI~OH/ 
H20 (22:9:1:0.26) as the solvent. Quantitation of individual phospholipid 
species was by scintillation counting. 
Results 
A  Subset of"Bypass SEC14p" Mutations Affect 
CDP-Choline Pathway Function 
Disruption of structural genes for enzymes of the CDP-cho- 
line pathway (e.g., CK/and CP'//; see Fig. 1 A) effects bypass 
of the  normally  essential  SEC14p  requirement  for  Golgi 
secretory function (Cleves et al., 1989,  1991b). Mutation of 
any one of at least five other genes (i.e., BSR2, BSR3, SAC1, 
BSD1, and BSD2) is also sufficient to relieve yeast cells of 
their SEC14p  requirement.  To determine if inactivation of 
CDP-choline pathway function is a  common feature of the 
"bypass SEC14p" alleles of the remaining five genes we have 
thus far identified, representative mutants were subjected to 
a  [t'C]choline radiolabeling regimen and  analyzed for ra- 
diolabeled PC content. As shown by the data in Fig. 2, the 
bsdl, bsd2,  and sad  mutants  were all as proficient as the 
wild-type strain  in  incorporation of [~4C]choline into  PC. 
Thus,  the corresponding wild-type gene products were not 
required for efficient synthesis of PC via the CDP-choline 
pathway in yeast. By contrast, the bsr2-5 and bsr3-2 muta- 
tions resulted in marked defects in [t4C]choline incorpora- 
Figure 1. Pathways for PC biosynthesis in yeast and the PI/PC hy- 
pothesis for SEC14p function in vivo. (tl) The two pathways  for 
phosphatidylcholine synthesis in yeast are shown. Genes encoding 
the structural enzymes of each pathway are indicated at the site of 
action of their respective gene products. Phosphatidic acid (PA); 
CDP-diacylglycerol (CDP-DAG); phosphatidylserine (PS); phos- 
phatidylethanolamine  (PE);  phosphatidylmonomethylethanol- 
amine (PMME); phosphatidyldimethylethanolamine  (PDME); and 
phosphatidylcholine (PC). (B) The PI/PC hypothesis posits that 
SECI4p maintains an appropriately elevated PI/PC ratio in yeast 
Golgi membranes,  a  ratio that  is proposed to be a  critical de- 
terminant  of yeast Golgi secretory competence  (Cleves  et  al., 
1991a,b). 
tion into PC (Fig. 2), and the magnitude of these defects was 
at least as great as those exhibited by mutants harboring in- 
dividual disruptions of structural genes for enzymes of the 
CDP-choline pathway (i.e., cki-284:  :HIS3 and cptl: :LEU2, 
respectively). These [14C]choline incorporation data, when 
coupled with genetic data that indicate these bsr2 and bsr3 
alleles to be recessive mutations (Cleves et al., 1991b), iden- 
tify the BSR2 and BSR3 gene products as being required for 
CDP-choline pathway  function  in  vivo.  A  combination of 
p4C]choline tracer experirnents and integrative genetic map- 
ping  data have  identified BSR2 as the  structural  gene  for 
the enzyme cholinephosphate cytidylyltransferase (CCTase) 
that catalyzes the second reaction of the CDP-choline PC 
biosynthetic pathway (Fig.  1 A), whereas BSR3 encodes an 
activity that appears to influence expression of active CCTase 
in vivo (manuscript in preparation). These data distinguish 
two general classes of "bypass SEC14p" mutants; those that 
are deficient in  CDP-choline pathway function (cki, bsr2, 
bsr3, cptl ),  and those that are not (bsdl, bsd2,  and sad ). 
The latter class of "bypass SEC14p" mutants will be treated 
in detail elsewhere. 
Bulk Membrane Phospholipid Profiles in lnositol- and 
Choline-containing Medium 
The PI/PC hypothesis predicts that the relative PI/PC con- 
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choline  into  PC.  The  indi- 
cated  strains  were  grown to 
mid-logarithmic growth phase 
in medium containing inositol 
(1  mM) but  lacking choline. 
Cells were pulse radiolabeled 
for 20 min with [t4C]choline 
(1 #Ci/ml), collected by filtra- 
tion,  and  washed to  remove 
any  unincorporated  radio- 
label.  Glycerophospholipids 
were  subsequently  extracted 
from the washed cells and resolved by one-dimensional paper chro- 
matography as described in Materials and Methods. The various 
loads were normalized to incorporation of [14C]choline into ceils 
(i.e.,  filtration-resistant material).  Each lane represents glycero- 
phospholipid extracted from 750,000 cpm  [14C]choline incorpo- 
rated into cells. Strains used were: WT, CTY182; sec144% CTY1- 
IA; cki-284::HIS3, CTY392; cptl::LEU2, CTY434; bsr2-5, CTY105; 
bsr3-2,  CTY156; sac1-16, CTY10; bsd1-124, CTY124; bsd2-1, 
CTY31. The complete genotypes of the strains employed are given 
in Table I. 
tent of Golgi membranes is directly dependent on SEC14p 
activity (Cleves et al.,  1991a,b).  Possible mechanisms of 
SEC14p bypass by inactivation of the CDP-choline pathway 
include:  (a)  a  wholesale alteration in bulk membrane PL 
composition in such mutants; and (b) a local effect on the PC 
content of Golgi membranes (Cleves et al., 1991a).  To inves- 
tigate the former possibility, we employed [32p]-orthophos- 
phate (32p~) radiolabeling methods to quantitate the effects 
of ~aypass SEC14p" mutations on general phospholipid me- 
tabolism in yeast grown in the presence of inositol and cho- 
line. Under pulse-radiolabeling conditions (30 min), the ra- 
diolabeled PL profile measured for wild-type cells consisted 
of  42% PI, 19% PC, 17% phosphatidylserine (PS), and 14% 
phosphatidylethanolamine (PE) (Table II). We infer the rela- 
tive rates at which each PL species was synthesized during 
the pulse by the percentage of 32Pi incorporation into each 
individual PL species. A relative comparison of PI with re- 
spect to PC yielded a PI/PC ratio of 2.19 (Table II). Under 
these same experimental conditions, the isogenic sec14-1  ~ 
strain exhibited a  bulk membrane radiolabeled PL profile 
and an efficiency  of incorporation into glycerophospholipid, 
on a  per cell basis,  that  was  essentially indistinguishable 
from that of the wild-type strain (PI/PC ratio =  1.95; Table 
II).  Thus,  the  sec14-1  '~  allele did  not  exert a  measurable 
effect on bulk yeast membrane  PL biosynthetic rates.  In 
marked  contrast,  the  cki-284::HIS3,  bsr2-5,  bsr3-2,  and 
cptl::LEU2 mutants exhibited substantially reduced rates of 
bulk membrane PC  synthesis.  These strains  incorporated 
only 5, 3, 5, and 3 % of total lipid 32Pi into PC, respectively, 
even though these strains exhibited efficiencies of 32pi incor- 
poration into glycerophospholipid that were comparable to 
those exhibited by wild-type and sec14-1  ts strains (Table II). 
These  reductions  in  PC  biosynthetic rate  were  observed 
Table II. Pulse and Steady-state Phospholipid Profiles of Yeast Grown in PC* Media 
Strain  I+C  ÷ Radiolabeling 
Pulse 
PI  PS  PC  PE  cpm/10  5 ceils  PI/PC 
%  %  %  % 
WT  42.4  ±  5  17.2  ±  3  19.3  ±  4  13.5  ±  2  189  ±  11  2.20 
secl4-1  42.0  ±  6  13.8  ±  2  21.6  ±  4  14.9  ±  4  183  ±  9  1.94 
cki-284::HIS3  43.9  ±  5  16.3  ±  4  5.0  ±  3  20.5  ±  4  171  ±  9  8.78 
bsr2-5  39.2  ±  3  19.5  ±  4  2.7  ±  1  25.2  ±  5  237  ±  15  14.52 
bsr3-2  40.8  ±  4  15.6  ±  3  5.0  ±  2  23.9  ±  4  177  ±  10  8.16 
cptl::LEU2  46.1  ±  8  21.6  ±  5  2.9  ±  4  19.4  ±  3  171  ±  10  15.90 
Steady State 
Pl  PS  PC  PE  PI/PC 
WT  24.2  ±  2  (112  +  8)  9.3  ±  1 (46  +  3)  43.5  +  2  (186  +  10)  17.0  +  1 (79  ±  3)  0.56 
secl4-1  23.8  +  1 (114  -l- 9)  8.4  ±  1 (46  +  4)  45.4  +  2  (187  ±  7)  18.4  ±  2  (84  +  6)  0.52 
cki-284::HIS3  24.6  ±  2  (120  ±  10)  7.0  ±  2  (41  +  2)  41.0  ±  3  (187  ±  8)  17.3  ±  3  (65  ±  2)  0.60 
bsr2-5  41.2  ±  3  (145  ±  8)  9.8  ±  1 (36  ±  3)  30.1  ±  2  (122  ±  11)  7.7  ±  5  (52  ±  6)  1.37 
bsr3-2  30.2  ±  2  (114  ±  7)  9.4  ±  1 (30  ±  2)  41.6  ±  1 (133  ±  7)  13.9  ±  2  (54  ±  4)  0.73 
cptl::LEU2  21.7  ±  1 (107  ±  4)  8.6  ±  2  (40  ±  4)  39.6  ±  4  (175  ±  9)  13.1  ±  3  (64  ±  4)  0.55 
Pulse and steady-state phospholipid profiles of yeast grown in I+C  + media. For pulse-radiolabeling experiments,  the indicated strains were grown to mid-logarithmic 
growth phase at 25°C in medium containing  inositol and choline chloride (1 mM each) and pulse-radiolabeled  with [3:P]orthopbosphate (10 ~Ci/ml) for 30 rain. 
For steady-state radiolabeling  experiments, the indicated strains were grown for five to six generations  at 25°C in media containing myo-inositol and choline chlo- 
ride (1 mM, each)  supplemented  with [32p]orthophosphate to 10/~Ci/ml.  Glycerophospbolipids  were extracted, resolved, and quantitated  by liquid  scintillation 
counting as described in Materials  and Methods. In the pulse-radiolabeling  experiments, the relative rates of synthesis for each individual phospholipid  were in- 
ferred from the relative  proportion of label recovered in each pbospholipid species, and the mole percentage of label recovered in each individual  phospholipid 
species is presented in the % PL column. Rates of total phospholipid  synthesis were inferred from the incorporation  of [32p]orthophosphate into phospholipid and 
these data are expressed as cpm recovered in the total phospholipid extract per 105 cells. PI/PC ratio was determined as the quotient of cpm recovered in Pl and 
PC for each individual  strain. 
For steady-state  radiolabeling  experiments, phospholipid data for each strain are expressed both as the relative mole percentage of label recovered in each in- 
dividual phospholipid species and, in parentheses, as cpm recovered for each phospholipid species per 10  ~ viable cells.  PI/PC ratio was determined as the quo- 
tient of cpm recovered in PI and in PC for each individual  strain.  Values presented represent averages from at least three independent trials.  Strains used were: 
WT, CTYI82; secl4-1 is, CTYI-1A; cki-284::HlS3, CTY392;  cptl::LEU2, CTY434;  bsr2-5, CTY105;  bsr3-2, CTY156;  sacl-16,  CTYI0; bsdl-124,  CTY124; 
bsd2-1, CTY31.  The complete genotypes of these strains  are given in Table I. 
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sis, although radiolabeled PE levels were somewhat elevated 
in these strains relative to wild type. Consequently, the bulk 
PI/PC ratios for these mutants were dramatically increased 
relative to the PI/PC ratio of the wild-type strain (Table II). 
On the basis of these data, we conclude that the alterations 
in phospholipid synthesis described above reflect specific 
defects in synthesis of a particular lipid species, and not a 
general defect in lipid synthesis per se. 
Under a steady-state radiolabeling regimen, PC, PI, PS, 
and PE constituted some 45, 24, 9, and 17% of total mem- 
brane PL in wild-type and sec14-1  's strains (Table II). The 
corresponding PI/PC  ratios were 0.56 and 0.52  for these 
strains,  respectively. However, the steady-state PL profiles 
obtained for the cki-284: :HIS3, bsr3-2, and the cptl: :LEU2 
"bypass SEC14p" mutants were similar to those of the wild- 
type and sec14-1  's strains, as were the corresponding steady- 
state  PI/PC  ratios  (Table II).  Moreover,  the  steady-state 
efficiencies of 32Pi incorporation  into  each  lipid  species 
were comparable for all of the strains used (Table II). Thus, 
the PC biosynthetic defects observed in the pulse experi- 
ments for these CDP-choline pathway-deficient strains were 
largely corrected at steady-state.  Nevertheless, the bsr2-5 
mutant still exhibited a significant reduction in the steady- 
state PC content of bulk membranes in the face of a substan- 
tially normal efficiency of 32Pi incorporation into glycero- 
lipid.  PC  constituted only 30%  of total PL in this  strain 
whereas 45 % of  total PL in the wild-type strain was PC. This 
reduction in PC, when coupled with a significant increase in 
bulk PI content (41%  of total  PL) in the bsr2-5 mutant, 
yielded a  bulk PI/PC ratio of 1.37;  a  ratio some 2.6-fold 
higher than that of wild-type membranes (Table II). 
These data demonstrate that CDP-choline pathway dys- 
function resulted in a clear reduction in the relative rate of 
PC biosynthesis, as inferred by the specific reduction in the 
rates of incorporation of labeled precursors into PC, and ef- 
fected dramatic increases in the radiolabeled PI/PC ratios of 
bulk membranes when cells were grown in I+C  ÷ medium. 
With the exception of the bsr2-5 mutant, these PL imbal- 
ances were largely corrected at steady-state. Moreover, since 
inactivation of the CDP-choline pathway reduced the rate of 
PC biosynthesis four- to sevenfold, these data demonstrate 
that  the  32p~ pulse-radiolabeling  regimen  predominantly 
measured the rate of PC synthesis via the CDP-choline path- 
way when cells were grown in I+C  ÷ medium. 
The Choline Salvage Activity of the CDP-Choline 
Pathway Is Required for the Maintenance of Norraal 
Cellular PC Biosynthetic Rates 
CDP-choline pathway dysfunction effects a bypass of SEC14p 
in choline-free medium but removal of choline from the me- 
dium does not affect the cellular requirement for SEC14p 
(Cleves et al.,  1991b).  Under choline-free growth condi- 
tions, the CDP-choline pathway is relegated to a salvage ac- 
tivity that can reincorporate the choline liberated by PC turn- 
over back into newly synthesized PC, but is not capable of 
sustaining net cellular PC biosynthesis. Thus, we assessed 
the contribution of CDP-choline pathway activity to PL bio- 
synthetic rates and bulk membrane PL composition when 
cells  were  cultured  in  inositol-  and  choline-free medium 
(I-C-).  The data are shown in Table III.  When wild-type 
yeast were grown in choline-free medium at 25°C, PI, PS, 
PC, and PE represented some 11, 20,  13, and 15% of total 
32pi-labeled PL,  respectively, when a  30-min pulse-radio- 
labeling regimen was  followed.  The PI/PC  ratio of these 
membranes was  0.84.  The pulse profile of PLs recovered 
from the isogenic secl4-1 's mutant was very similar to that 
measured in wild-type cells, and the corresponding PI/PC 
ratio and efficiency of incorporation of radiolabel into glyc- 
erophospholipid  was  also  similar  (Table  III).  Thus,  the 
secl4-1 '~ allele did not exert any measurable effect on bulk 
PL biosynthetic rates when cells were grown in I-C- me- 
dium.  Disruption of CDP-choline pathway function in the 
cki-284::HIS3,  bsr2-5,  bsr3-2, and cptl::LEU2  mutants re- 
suited in dramatic reductions in incorporation of 32pi into 
PC. In no case did PC content exceed 5 % of total labeled 
PL, even though the efficiencies of incorporation of radiolabel 
into glycerolipid were not significantly affected in these mu- 
tants (Table III). Moreover, these mutants displayed signifi- 
cantly elevated PI/PC ratios ranging from 1.58 for the cki- 
284::HIS3 strain to  10.15 for the bsr2-5 strain. 
Bulk membranes prepared from wild-type cells grown in 
I-C-  medium  exhibited 40%  PC,  12%  PI,  10%  PS,  and 
13 % PE at steady-state (Table II.I). The corresponding PI/PC 
ratio  was  0.30.  Again,  the  sec14-1  's,  cki-284::HIS3,  and 
cptl::LEU2  mutants  each exhibited nearly normal steady- 
state PL profiles, efficiencies of incorporation of 32p~ into 
glycerolipid, and PI/PC ratios. Both the bsr2-5 and bsr3-2 
mutants,  however, exhibited significant alterations in their 
PL profiles. In the former case, the PC content (37%) was 
similar to that of wild type while the PI content (22%) was 
considerably higher,  leading to a  steady-state PI/PC ratio 
(0.58)  that was  nearly double that of the wild-type strain 
(0.30).  Likewise, the bulk membranes prepared from the 
bsr3-2 strain displayed increased steady-state levels of  PI and 
an elevated PI/PC ratio, yet neither the bsr2-5 strain nor the 
bsr3-2 strain exhibited significant alterations in their ability 
to incorporate radiolabel into glycerolipid (Table HI). We 
have repeated these steady-state analyses for all of these mu- 
tants  (cptl  mutants  excluded)  in  I-C  + medium  and  have 
found that the bulk PL compositions were essentially the 
same  as  the corresponding compositions measured when 
these strains were grown in I-C- medium (data not shown). 
Thus, the alterations in bulk PL composition measured for 
bsr2-5 and bsr3-2 mutants grown in the absence of inositol 
were  independent  of the  choline  content  of the  growth 
medium. 
These data demonstrate that CDP-choline pathway activ- 
ity was required for the maintenance of normal bulk PL bio- 
synthetic rates and, at least in the case of the bsr2 and bsr3 
mutants, for the steady-state maintenance of normal PI and 
PC levels in bulk yeast membranes even when cells were 
grown in choline-free medium; i.e., a condition where the 
CDP-choline pathway is a choline salvage activity that can- 
not contribute net PC synthesis to the yeast cell. With respect 
to  the  former point,  the  finding  that  inactivation  of the 
CDP-choline pathway resulted in an approximately threefold 
decrease in the rate of PC biosynthesis in cells grown in 
I-C-  medium  relative to  wild-type cells  reveals  that  PC 
synthesis via the choline salvage activity of the CDP-choline 
pathway is a significant contributor to PC biosynthetic rates 
in yeast grown under choline-free conditions. 
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Strain  I-C- Radiolabeling 
Pulse 
PI  PS  PC  PE  epm/10  ~ cells  PI/PC 
%  %  %  % 
WT  10.7  5- 2  20.0  5- 5  12.8  5:3  15.3  5:4  211  5:24  0.84 
secl4-1  12.0  5- 3  16.2  5- 4  13.3  5- 4  14.8  5- 4  189  5- 28  0.90 
cki-284::HIS3  8.5  5-  1  24.2  +  5  5.4  5:2  21.4  5:6  196  5-  16  1.57 
bsr2-5  18.1  5- 4  23.7  5- 5  1.8  5:1  21.8  5- 5  230  5:15  10.15 
bsr3-2  10.9  5- 2  29.6  5- 6  2.1  5-  1  24.3  5- 6  182  5:14  5.19 
cptl::LEU2  15.5  5- 5  29.4  5- 5  4.5  5:2  14.9  5-  3  169  5- 23  3.44 
Steady State 
PI  PS  PC  PE  PI/PC 
WT  12.0  +2  (86  +4)  10.2  +2(64  +  3)  40.1  -t- 3  (243  ±  9)  13.1  -I-2  (92  +5)  0.30 
sec14-1  14.4  +2  (72  +  5)  9.4  +  2(60  +  2)  43.6  +  2(226  ±  8)  14.4  +  1 (84  ±  3)  0.33 
cki-284::HIS3  12.5  +  1  (68  +  4)  9.8  +  1 (54  +  4)  46.5  +  4  (244  +  10)  16.6  +  2  (83  5: 4)  0.27 
bsr2-5  21.5  +  2  (117  +  11)  8.8  +  1 (56  5:  3)  36.9  +  3  (187  5-  7)  19.7  +  3  (86  +  5)  0.58 
bsr3-2  25.4  +  2  (87  5-  7)  9.8  5-  1 (39  5- 5)  39.4  +2(144  5- 6)  17.3  5-2(70  +4)  0.65 
cptl::LEU2  13.8  5-  1  (72  5- 6)  10.3  5-  3  (53  +  4)  43.1  5:4  (224  5-  8)  19.2  5- 2  (86  5: 3)  0.22 
Pulse and steady-stall phospholipid profiles of yeast grown in I-C- medium. For pulse-radiolabeling experiments, the indicated strains were grown to mid-logarithmic 
growth phase at 250C in inositol and choline-free medium and pulse-radiolabeled  with [32p]orthophosphate (10 #Ci/ml) for 30 min. For steady-state radiolabeling 
experiments, the indicated strains were grown for five to six generations  at 25"C in inositol and choline-free medium supplemented  with [32p]orthophosphall to 
10 #Ci/ml. Glycerophospholipids  were extracted,  resolved, and quantitated by liquid scintillation counting as described in Materials  and Methods. In the pulse- 
radiolabeling  experiments, the relative  rates of synthesis for each individual phospholipid were inferred from the relative proportion of label recovered in each 
phospholipid species, and the mole percentage of label recovered in each individual phospholipid species is presented in the % PL column.  Rates of total phos- 
pholipid synthesis were inferred from the incorporation  of [32p]orthophosphate into phospholipid and these data are expressed as cpm recovered in the total phos- 
pbolipid extract per 10  ~ cells. PI/PC ratio was determined as the quotient of epm recovered in PI and PC for each individual strain.  For steady-stall radiolabeling 
experiments, phospholipid data for each strain are expressed both as the relative mole percentage of label recovered in each individual phospholipid species and, 
in parentheses, as cpm recovered for each phospholipid species per 106 viable cells. PI/PC ratio was determined as the quotient of cpm recovered in PI and in 
PC for each individual strain.  Values presented represent averages from at least three independent trials.  Strains used were: I,t"T, CTY182;  sec14-P  ~, CTYI-IA; 
cki-284::HIS3, CTY392; cptl::LEU2, CTY434; bsr2-5, CTY105; bsr3-2, CTYI56; sac1-16, CTY10; bsd1-124, CTY12,1; bsd2-1, CTY31.  The complete geno- 
types of these strains are given in Table  I. 
cptl and eptl Mutations Are Distinguished 
by Their Effects on PC Biosynthesis via the 
CDP-Choline Pathway In Vivo 
The EPT/and CPT/gene products are ethanolamine- and 
choline-phosphotransferases,  respectively,  that  are  each 
able to efficiently catalyze the ultimate reaction for PC bio- 
synthesis via the CDP-choline pathway in vitro (Hjelmstad 
and Bell,  1987; Hjelmstad and Bell,  1988).  Nevertheless, 
cptl disruption mutations effect a bypass of SEC14p whereas 
eptl disruption mutations do not (Cleves et al.,  1991b). As 
a common feature of CDP-choline pathway defects that by- 
pass SEC14p is a reduction in the cellular rate of PC biosyn- 
thesis (see above), we tested the effect of an eptl::URA3 al- 
lele on  the  efficiency of PC  synthesis in  vivo.  Whereas 
cptl::LEU2 mutants were clearly defective in the incorpora- 
tion of [~4C]choline into PC, and suffered markedly reduced 
rates of PC biosynthesis when cells were grown either in 
I÷C  + or I-C- medium (Fig. 2, Tables II and III), eptl::URA3 
mutants were not significantly compromised for PC biosyn- 
thesis. Yeast strains carrying eptl::URA3 exhibited normal 
rates of [~4C]choline incorporation into PC,  and the bulk 
membrane PL profiles of eptl::URA3 cells were indistin- 
guishable from those of wild type in both 32Pi pulse radio- 
labeling  and  steady-state  radiolabeling  experiments  that 
were performed with cells growing in either I÷C  ÷ or I-C- 
medium (data not shown). These results indicate that, even 
though the CPT/and EPT/gene products exhibit functional 
redundancy in vitro, these enzymes are not functionally re- 
dundant with respect to PC synthesis in vivo, Moreover, these 
data further strengthen the relationship between the ability 
of yeast cells to synthesize PC via the CDP-choline pathway 
and the essential SEC14p requirement of  yeast cells for Golgi 
secretory function and cell viability. 
Characterization  of Yeast Golgi Membrane Purity 
The PI/PC hypothesis predicts that the relative PI/PC con- 
tent of Golgi membranes is directly dependent on SEC14p 
activity (Cleves et al.,  1991a,b).  To directly monitor the 
phospholipid content of yeast Golgi membranes, we devel- 
oped a Golgi enrichment procedure to obtain sufficient  quan- 
tities of highly purified Golgi membranes for biochemical 
analysis. This method involves serial differential centrifuga- 
tion steps followed by two successive equilibrium gradient 
centrifugation steps (Cleves et al., 1991b; see Materials and 
Methods).  However,  since  meaningful analyses of Golgi 
membrane PL content require a very high degree of Golgi 
membrane purity, we characterized in detail the purity of the 
Golgi membranes recovered from lysates prepared from a 
wild-type yeast strain (CTY182;  see Table I). Characteriza- 
tion of  the recoveries of marker proteins that identify defined 
organelles  in  the  most  highly  enriched  Golgi  fractions 
demonstrated that this procedure yielded an excellent recov- 
ery of KEX2p (ca. 60% of total), a resident integral mem- 
brane protein of  the yeast Golgi (Fig. 3 A). These Golgi frac- 
tions represented a 185-200-fold enrichment of KEX2p over 
total cell lysate under all of the various experimental condi- 
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Marker  Organelle  Percent 
KEX2p  Golgi  57.1% 
GMP  Golgi  52.4% 
CC Reductase  ER  0.2% 
DPAP-B  Vacuole  0.9% 
PM  ATPase  PM  0.4% 
F1 ~-ATPase  Mitochondria  0.1% 
Figure 3.  Purity of yeast Golgi membrane preparations. (A) The 
distribution of the Golgi marker enzyme, KEX2p, and of Golgi 
membrane proteins (GMPs) through the Golgi enrichment proce- 
dure is shown (top). The percentage of total starting KEX2p (m) 
and of GMP signal ([]) recovered in the  12,000 g  supernatant 
(S/2), 12,000  g pellet (P12), 100,000 g supernatant (S/00), 100,000 g 
pellet (PIO0), GI, and G2 fractions. G1 represents the peak KEX2p 
fraction pool obtained after resolution of  the P100 in a 30-80% sor- 
bitol equilibrium gradient (see Materials and Methods). G2 repre- 
sents the most highly purified Golgi membrane fraction and was ob- 
tained  by  resolution  of the  G1  fraction  in  a  40-65%  sorbitol 
equilibrium gradient, again as previously described (Cleves et al., 
1991b). Also tabulated is the percent recovery of defined markers 
from the most purified Golgi fractions (G2) relative to total marker 
present in the unfractionated cell-free lysate (bottom). The propor- 
tion of total starting signal for Golgi, endoplasmic reticulum (ER), 
vacuole, plasma membrane (PM), and mitochondrial marker en- 
zymes present in the G2 fraction is given. Marker enzymes were 
determined as described in Materials and Methods. (B) Colocaliza- 
tion of GMPs and the Golgi marker KEX2p. To visualize KEX2p, 
fixed, and permeabilized cells of the KEX2p-overproducer strain 
CTY234 were  incubated with  afffinity-purified  polyclonal rabbit 
anti-KEX2p serum and Texas red sulfonyl chloride (TRSC)-con- 
jugated donkey anti-rabbit  IgG. GMPs were visualized with pri- 
mary anti-GMP mouse polyclonal antibodies and developed with 
FITC-conjugated sheep anti-mouse IgG. Displayed here are repre- 
sentative panels of  cells that were analyzed via this double-label im- 
munofluorescence regimen.  The top panels  record  the  KEX2p 
profile while the bottom panels record the corresponding GMP 
profile. Appropriate controls demonstrated the specificity of  the an- 
tisera and the spectral separation of the fluorochromes under the 
photographic conditions employed (not shown). Other technical 
details are presented in the Materials and Methods. 
tions used in this study and were substantially free of mark- 
ers diagnostic of endoplasmic  reticulum (ER),  mitochon- 
drial, vacuolar, and plasma membranes. 
To gain an independent measure of the purity of these 
Golgi membranes, we raised a polyspecific polyclonal an- 
tiserum in mice against bulk integral membrane proteins of 
the most highly enriched Golgi fractions (see Materials and 
Methods). We will henceforth refer to this population of inte- 
gral membrane proteins as GMPs (Golgi Integral Membrane 
Proteins).  This  anti-GMP  serum  recognized 7-10  major 
polypeptides,  as judged  by  immunoblotting  experiments, 
and revealed a polypeptide pattern that was similar to that 
observed when GMPs were displayed by SDS-PAGE and 
visualized by silver  staining  (manuscript in  preparation). 
This antiserum was then used to compare the distribution of 
GMPs with that of KEX2p throughout the Golgi enrichment 
procedure,  and  to  assess  the  degree of colocalization of 
GMPs with Golgi membranes (i.e., KEX2p) in double-label 
indirect immunofluorescence experiments. As shown by the 
data presented in Fig.  3 A,  the distribution of the GMPs 
throughout the Golgi enrichment procedure was very similar 
to that of the Golgi marker KEX2p, and the yield of GMPs 
was comparable to that of KEX2p. The most highly enriched 
Golgi fraction contained 57 and 52 % of the total KEX2p and 
GMPs, respectively (Fig. 3 A), yet we estimate this fraction 
contained only an approximately 0.3 % recovery of total cel- 
lular glycerophospholipid (not shown). 
For  double-label  indirect  immunofluorescence  experi- 
ments we employed strain CTY234, a KEX2p overproducing 
strain (Table I), as it has previously been shown that yeast 
bearing the KEX2 gene on a multicopy plasmid exhibit nor- 
real localization of KEX2p, and that the amplified KEX2p 
staining can be readily detected without having to resort to 
antibody sandwich methods (Franzusoff et al.,  1991;  Red- 
ding et al.,  1991).  Fig. 3 B shows representative GMP and 
KEX2p staining patterns that were observed in fixed yeast 
cells.  Both the GMP and KEX2p staining profiles largely 
consisted of three to 15 randomly distributed punctate bod- 
ies per cell, and were very similar to the KEX2p staining 
profiles previously described (Cleves et al., 1991; Franzusoff 
et al.,  1991; Redding et al.,  1991).  Preimmune serum col- 
lected from the mouse from which the anti-GMP serum was 
derived gave no detectable signal in control immunofluores- 
cence experiments (not shown). Further comparison of these 
localization profiles revealed a high coincidence of the punc- 
tate GMP and KEX2p signals.  Finally, the lack of GMP- 
specific staining of cellular membranes that did not contain 
KEX2p was particularly noteworthy (Fig. 3 B). These col- 
lective biochemical fractionation and immunofluorescence 
localization data indicate a high level of  purity of  the isolated 
Golgi membranes. We note, however, that we were able to 
achieve this requisite purity of Golgi membranes only when 
cells were cultured in YPD and not when cells were grown 
in minimal media (not shown). 
The PC Content of Yeast Golgi 
Membranes Varies as a Direct Function 
of SEC14p Activity 
To directly test the dependence of Golgi membrane PL com- 
position on SEC14p activity, we analyzed the PL composi- 
tion of purified Golgi membranes under various conditions 
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in Fig. 4 A, the wild-type PL composition of Golgi mem- 
branes was distinct from that of bulk membranes. -Whereas 
bulk membranes consisted of 50, 21, 4, and 20% of PC, PI, 
PS, and PE, respectively, Golgi membranes were composed 
of nearly equivalent mole percentages of each of these PL 
species. These values translated into a PI/PC ratio of 0.42 
for bulk membranes and 1.04 for Golgi membranes, a 2.5- 
fold difference in PI/PC ratio between these two membrane 
preparations. Moreover, neither the bulk nor the Golgi mem- 
brane PL compositions of wild-type cells were affected by 
shift to 37°C (Fig. 4A). 
A  distinguishing feature of sec14-1 '=  strains is that these 
mutants exhibit a dramatic exaggeration of the Golgi com- 
plex upon shift to 37°C.  This phenotype is considered to 
reflect continued membrane and protein flow into the Golgi 
complex from the early stages of the secretory pathway with- 
out the normal balance of SEC14p-dependent membrane and 
protein exit from the Golgi into the latest stages of the secre- 
tory pathway (Novick et al., 1980). Thus, the yeast Golgi PL 
composition of sec14-1 '~ mutants should be significantly al- 
tered  as  a  secondary  consequence  of imposition  of the 
sec14-1 ~ secretory block. The data presented in Fig. 4 B in- 
dicate that both the bulk membrane  (PI/PC  =  0.39)  and 
Golgi membrane (PI/PC =  0.96) PL compositions of sec14- 
1 '= cells grown at 25°C were very similar to the correspond- 
ing membrane PL compositions of wild-type cells. However, 
although shift of sec14-1 ~ mutants to 37°C did not signifi- 
cantly alter the bulk membrane PL composition in these mu- 
tants, this temperature shift effected a dramatic change in the 
sec14-1 '= Golgi PL profile (Fig. 4 B). The Golgi PL compo- 
sition became similar to the bulk membrane composition 
(PI/PC =  0.39). We note that, under these restrictive condi- 
tions,  the  fractionation  properties  of the  sec14-1 '=  Golgi 
changed  slightly in that the compartment became denser. 
Nevertheless,  we  were  able  to  enrich  for sec14-1 '=  Golgi 
membranes some  150-fold over crude lysate (not shown). 
These data indicate that the sec14-1 '= mutation did not affect 
either bulk or Golgi membrane PL compositions at the per- 
missive temperature of 25°C,  nor did sec14-1 '= affect bulk 
membrane PL composition at the restrictive temperature of 
37°C.  Rather, the secl4-1 '= defect became apparent only at 
the level of Golgi membranes. In addition, this dramatic al- 
teration of Golgi PL profile by imposition of the secl4-1 '= 
block was not some completely nonspecific consequence of 
secretory pathway dysfunction or general growth arrest as it 
was  not  observed  when  either  the  secll  '=  or  the  secl5  '= 
secretory blocks were imposed on the corresponding mu- 
tants by temperature shift to 37°C (not shown). The sec11 '= 
mutation  causes  defects  in  signal  peptide  cleavage  from 
secretory glycoproteins and delays their export from the ER 
(Schauer et al.,  1985; Bohni et al.,  1988). The sec15  *= mu- 
tation blocks fusion of Golgi-derived secretory vesicles to 
the plasma membrane (Novick et al.,  1980). 
To measure Golgi membrane PL content as a direct func- 
tion of SEC14p activity, it was necessary to uncouple Golgi 
secretory function from its usual SEC14p requirement be- 
cause of the Golgi PL alterations that likely occur simply as 
an indirect consequence of imposition of the secl4-1 '= secre- 
tory block (see above). We achieved this end by using strain 
CTY31, a sec14-1 '= strain that also carries the bsd2-1  allele 
(see Table I). The bsd2-1 allele is a "bypass SEC14p" muta- 
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Figure 4.  Phospholipid composition of bulk yeast membranes and 
Golgi membranes. For these experiments, yeast strains with the in- 
dicated relevant genotypes were grown to mid-logarithmic phase at 
25°C in YPD medium and, where indicated, shifted to 37°C for 
75 min prior to harvesting of cells to induce dysfunction of the 
sec14-1 t=  gene product  (Secl4p").  Samples were  removed from 
each culture prior to generation of spheroplasts and determination 
of bulk membrane PL composition as described in the Materials 
and Methods. Golgi membranes were subsequently purified from 
the  remainder  of the  culture,  and  individual  PL species  were 
resolved by two-dimensional paper chromatography and quanti- 
tated by phosphorus assay (see Materials and Methods).  Values 
presented are the mole percentage of total glycerolipid phosphorus 
represented by each individual phospholipid species (n = 3). Quan- 
titation of  the major phospholipids of  yeast, that is phosphatidylser- 
ine  (PS),  phosphatidylethanolamine  (PE),  phosphatidylcholine 
(PC), and phosphatidylinositol (PI), is indicated for both bulk cell 
membranes and purified Golgi membranes. Minor species such as 
phosphatidic  acid  (PAl,  cardiolipin  (CL),  phosphatidylmono- 
methylethanolamine (PMME), and phosphatidyldimethylethanol- 
amine (PDME) collectively constituted less than 1% of total phos- 
pholipid. Inset values reflect the average PI/PC ratio displayed by 
each membrane preparation. Strains used for each panel were: (A) 
CTY182; (B) CTYI-IA; (C) CTY479; (D) CTY31 (see Table I). 
tion that relieves Golgi secretory function from its  usual 
SEC14p  requirement (Cleves et al.,  1991b),  but  does  so 
without effecting wholesale alterations in bulk membrane PL 
composition or content. The steady-state bulk membrane PL 
compositions of the bsd2-1,  SEC14 strain (Fig. 4 C) and the 
bsd2-1,  sec14-1 '=  strain  (Fig.  4  D)  were  indistinguishable 
from those of the wild-type strain (Fig. 4 A). Golgi mem- 
branes prepared from the bsd2-1,  SEC14 strain exhibited a 
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whether the strain had been subjected to the 37°C tempera- 
ture shift, or not (Fig. 4, compare C with A). A normal Golgi 
membrane PL profile was  also  measured for the bsd2-1, 
sec14-1 's mutant (PI/PC  =  0.9)  when it was uniformly in- 
cubated  at  a  temperature  (25°C)  permissive  for  Secl4p  ~ 
(Fig. 4, compare D with A). Thus, the bsd2-1 mutation alone 
did not measurably alter relative Golgi membrane PL com- 
position either at 25 ° or 37°C under SEC14p-proficient  con- 
ditions. Furthermore, wild-type Golgi membranes were esti- 
mated to contain 43.6 (5-  2.6)  nmoles glycerophospholipid 
per  mg  Golgi protein  after  shift to  37°C,  while bsd2-1, 
SEC14  Golgi membranes were measured to contain 39.7 
(± 2.4) nmoles glycerolipid per mg protein under the same 
culture conditions. Thus, the bsd2-1 mutation alone also did 
not measurably alter the Golgi membrane PL: protein ratio 
at 37°C under SEC14p-proficient  conditions. However, inac- 
tivation of Secl4p  ~ by temperature shift to 37°C resulted in 
nearly a doubling of the relative Golgi membrane PC content 
in the bsd2-1,  sec14-1 's strain (PI/PC  =  0.57;  Fig. 4, com- 
pare D to A and C); despite the fact that this mutant is en- 
tirely proficient in Golgi secretory function and cell growth 
at  this  normally  restrictive  temperature  (Cleves  et  al., 
1991b). Moreover, the marked increase in Golgi PC content 
in the bsd2-1,  sec14-1 's strain was not accompanied by dra- 
matic alterations in the relative Golgi content of the other 
PLs,  particularly  PS.  This  was  in  contrast  to  the  more 
general alterations in Golgi PL profile recorded upon impo- 
sition of the sec14-1', Golgi secretory block (Fig. 4 B). 
The observed alterations in Golgi phospholipid composi- 
tion of bsd2-1, sec14-1 '~ strain upon shift to 37°C, relative to 
that of the bsd2-1, SEC14 strain, could result from one of two 
effects: (a) a specific increase in net Golgi PC content in the 
bsd2-1,  sec14-1 '~  strain;  or  (b)  no change in Golgi mem- 
brane PC levels in the bsd2-1,  sec14-1 '~ strain superimposed 
upon a general reduction in the Golgi membrane content of 
the other glycerophospholipids.  To distinguish between these 
two possibilities, we compared the glycerophospholipid:pro- 
tein ratios of Golgi membranes prepared  from wild-type, 
bsd2-1, sec14-1 '~ and bsd2-1,  SEC14 yeast strains (see Mate- 
rials and Methods).  The first possibility predicted an in- 
crease in the Golgi phospholipid: protein ratio in the bsd2-1, 
sec14-1 t` strain relative to the wild-type and bsd2-1,  SEC14 
strains, while the latter predicted a relative decrease in the 
Golgi phospholipid:  protein  ratio  in  the  bsd2-1,  sec14-1 ,~ 
strain. Golgi prepared from the bsd2-1, sec14-1 ~ strain after 
shift to 37°C, was estimated to contain 53.9 (±  1.9) nmoles 
of glycerophospholipid per mg Golgi protein, as compared 
to the corresponding wild type and bsd2-1,  SEC14 values of 
43.6 (±  2.6) and 39.7 (±  2.4) nmoles glycerophospholipid 
per mg protein, respectively (see above).  This increase re- 
flected approximately a 24 % increase in total Golgi glycero- 
phospholipid (specifically PC) as a result of SEC14p  dys- 
function. Analysis of  each PL species as a function of protein 
indicated that Golgi membranes of a bsd2-1,  SEC14  strain 
shifted to 37°C exhibited approximately 11.6 nmoles PC per 
mg Golgi protein, while the isogenic bsd2-1,  sec14-1 ~ strain 
cultured under the  identical conditions exhibited a  Golgi 
membrane content of approximately 23.5 nmoles PC per mg 
protein.  Thus, the collective data indicate that,  while the 
nmoles PI, PS, and PE per mg Golgi protein present in bsd2-1, 
SEC14  and bsd2-1,  sec14-1 '~  Golgi membranes upon  shift 
to 37°C remained relatively unchanged, the nmoles PC per 
mg Golgi protein in bsd2-1, sec14-1 ~ Golgi membranes effec- 
tively doubled relative to the nmoles PC per mg protein in 
bsd2-1, SEC14 Golgi membranes upon shift to 37°C. This in- 
crease in the amount of PC relative to the amount of Golgi 
protein was reflected as an increase in total Golgi membrane 
phospholipid. These collective results indicate that the rela- 
tive increase in Golgi PC content observed as a direct conse- 
quence of SEC14p dysfunction  reflected a specific net increase 
in Golgi PC and not a condition of constant PC levels super- 
imposed upon reductions in Golgi PI, PS, and PE. We con- 
clude from these biochemical data that SEC14p functions to 
maintain a reduced PC content in yeast Golgi membranes. 
CDP-Choline  Pathway Dysfunction  Restores 
Wild-type Golgi PL Composition  to SECl4p-deficient 
Golgi Membranes 
"Bypass SEC14p" mutants carrying the secl4-1 's allele and 
either the cki-284::HIS3 or cptl::LEU2 alleles exhibited es- 
sentially wild-type bulk membrane profiles at steady-state, 
regardless of whether these strains were grown in I÷C  ÷ or 
I-C- medium (see above). As a result, it was of interest to 
determine whether these mutations eliminated the increase 
in Golgi PC measured under conditions of SEC14p dysfunc- 
tion.  The  secl4-1 '~,  cki-284::HIS3  mutant  was  used  for 
these studies. This mutant was grown at 25°C in YPD and 
shifted to 37°C,  prior to harvesting of cells, to inactivate 
Secl4p  ~ (see Materials and Methods). When grown in the 
YPD medium that we must employ for preparative purifica- 
tion of Golgi membranes, the seal4-1 ~, cki-284::HIS3  strain 
exhibited a steady-state bulk membrane PL profile that con- 
sisted of 33%  PI, 40%  PC, 7% PS, and 20%  PE, respec- 
tively (Fig. 5 A). Although this bulk membrane PL composi- 
tion was  similar to that exhibited by the isogenic seal4-1 's 
strain analyzed under these same conditions (Fig. 4 B), the 
profiles exhibited subtle differences. In particular, the cki- 
284::HIS3 strain exhibited some elevation in bulk membrane 
PI and a minor decrease in bulk membrane PC relative to 
the isogenic CKI derivative (compare Figs. 5 A and 4 B). 
Nonetheless, the Golgi membranes prepared from the sec14- 
1 's,  cki-284::HIS3  strain  exhibited  a  wild-type Golgi PL 
profile (compare Fig. 5 B with Fig. 4 A), and not the dramati- 
cally altered PL profile measured for either the isogenic 
secl4-1 '~,  CKI strain (compare Figs.  5 B and 4  B) or the 
congenic secl4-1 's,  bsd2-1  strain grown under these same 
conditions (compare Figs. 5 B and 4 D). Moreover, the phos- 
pholipid content of seal44 ~,  cki-284::HIS3  and wild-type 
Golgi membranes was measured to be similar when the cor- 
responding strains were cultured under the described condi- 
tions (45.3 -l- 3.1 and 43.6 +  2.6 nmole phospholipid per/zg 
protein,  respectively). Thus,  cki-284::HIS3  not only sup- 
pressed the lethality associated with SEC14p defects, but it 
concomitantly suppressed the relative increase in Golgi PC 
measured under conditions of SEC14p  dysfunction. 
Further confirmation of these results was obtained from 
analysis of the bulk and Golgi PL compositions of seal4-1 ~, 
bsd2-1,  cki-284::HIS3  triple mutants. These triple mutants 
exhibited essentially wild-type bulk and Golgi membrane PI 
and PC profiles (22 ±  3 and 24 +  2 mole% Golgi phospho- 
lipid, respectively) as well as Golgi phospholipid content per 
unit protein under Sec14p~-deficient conditions (38.2  ±  3.3 
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Figure 5. Golgi membrane phospholipid composition of secl4-1  ts, 
cki  double  mutants.  (A)  The  bulk  membrane  composition  of 
CTY392 (secl4-P, cki-284::HIS3) is shown. Glycerophospholipids 
were extracted from a culture of CTY392, which had been shifted 
to 37°C for 75 min, and were resolved and quantitated as described 
in Materials and Methods and in the legend to Fig. 3. (B) The PL 
composition of Golgi membranes prepared from strain CTY392 af- 
ter a 75 rain shift to 37°C is shown. Glycerophospholipids were ex- 
tracted from purified Golgi membranes and the mole percentage of 
each glycerolipid is indicated (n =  3). 
umole glycerophospholipid per mg protein as compared to 
43.6  +  2.6 nmoles glycerophospholipid per mg protein for 
wild-type Golgi membranes; see above), indicating that cki- 
284::HIS3 eliminated the marked increase in Golgi PC nor- 
mally observed in sec14-1% bsd2-1 strains  (see Fig.  4 D). 
These data suggest that PC synthesis via the CDP-choline 
pathway accounts for the net increase in Golgi PC that results 
from SEC14p dysfunction. 
SECI4p Overproduction  Specifically Depresses PC 
Synthesis via the CDP-Choline Pathway 
The collective genetic and biochemical data can be inter- 
preted to indicate either that: (a) SEC14p removes excess PC 
from Golgi membranes in vivo by virtue of its PL-TP activ- 
ity; or (b) that SEC14p serves to inhibit PC synthesis via the 
CDP-choline pathway in vivo. In the case of the latter sce- 
nario, such a regulation may largely represent a local effect 
on PC biosynthesis exerted at the level of Golgi membranes. 
A prediction of  that latter model, which distinguishes it from 
the PL transfer model, is that overproduction of SEC14p in 
yeast might result in a more general inhibition of cellular 
CDP-choline pathway activity in vivo. To test this hypothe- 
sis, we overproduced SEC14p in yeast by increasing SEC14 
gene dosage and estimated PC biosynthetic rates in such a 
SEC14p overproducing strain.  SEC14 gene dosage was in- 
creased by introducing a YEp(SEC14) plasmid into an ap- 
propriate yeast strain.  The YEp(SEC14) derivative strain 
routinely overproduced SEC14p some 5-10-fold as judged by 
quantitative immunoprecipitation, immunoblotting, and in 
vitro PI-transfer assays (not shown). As demonstrated by the 
32p~ pulse-radiolabeling data in Fig.  6 A,  a comparison of 
the bulk membrane PI, PS, and PE profiles of a wild-type 
yeast strain and its isogenic SEC14p-overproducing deriva- 
tive  demonstrated  that  these  profiles  were  very  similar, 
regardless of whether the strains were cultured in PC  ÷ or 
I-C-  media.  However,  the  pulse-radiolabeled bulk  mem- 
brane PC content of the SEC14p-overproducing strain was 
substantially reduced (2.5- to 3-fold) relative to that of the 
wild-type strain; irrespective of whether the corresponding 
yeast strains were grown in I+C  ÷ or I-C- media. Indeed, the 
magnitudes  of the  SEC14p-overproduction-dependent re- 
duction in bulk membrane PC  content of cells grown in 
I+C  + and I-C- media were very similar to those observed 
for cki-284::H1S3, bsr2, bsr3, and cptl::LEU2 yeast strains 
cultured under the  corresponding growth  conditions  (see 
above). The steady-state PL compositions of the wild-type 
and SEC14p overproducer strains were indistinguishable, in- 
dicating that the SEC14p-overproduction mediated effect on 
bulk PC content was  corrected at the level of steady-state 
(not  shown).  These  data  indicate  that  overproduction of 
SEC14p resulted in a general depression in the rate of cellu- 
lar PC biosynthesis. 
Since the rate of PC biosynthesis inferred from the pulse- 
radiolabeling experiments reflects predominantly PC synthe- 
sis via the CDP-choline pathway (see above), the reduction 
in pulse-radiolabeled bulk membrane PC content measured 
in  the  SEC14p-overproducing strain  likely represented  a 
specific reduction in  the  rate of PC  biosynthesis via  the 
CDP-choline pathway. To more directly assess CDP-choline 
pathway activity as a function of  SEC14p overproduction, we 
measured the time course of [l+C]choline incorporation into 
PC in a wild-type and SEC14p-overproducing yeast strain as 
a function of cell number. Representative data are presented 
in Fig.  6 B.  At all of the time points taken, the wild-type 
strain  exhibited an  approximately fourfold greater incor- 
poration  of  [14C]choline  into  PC  than  did  the  isogenic 
SEC14p-overproducing  strain.  Thus,  we  concluded  that 
SEC14p-overproduction effected a  significant reduction in 
the rate of PC biosynthesis via the CDP-choline pathway. 
Pulse-radiolabeling  of bulk  membrane  PC  with  [methyl- 
14C] methionine, a specific measure of PC biosynthesis via 
the PE methylation pathway, did not reveal a reduction in the 
efficiency of incorporation of this label into bulk membrane 
PC for the SEC14p-overproducing strain relative to the wild- 
type strain (Fig.  6  C).  These collective data suggest that 
overproduction of SEC14p effected a  marked and specific 
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Figure 6.  Overproduction of SEC14p inhibits the activity of the 
CDP-choline pathway. (.4) Wild-type strain CTY525 (m) and the 
isogenic SECI4p overproducing strain CTY521 ([]) were grown to 
mid-logarithmic phase at 25°C in the indicated media and pulse- 
radiolabeled with  [32P]orthophosphate (10 #Ci/ml)  for 30 rain. 
Synthesis of the major PLs was evaluated as described in Materials 
and Methods. Values presented represent the average mole percent- 
age of total lipid-extractable radiolabeled material (designated as % 
on the y-axis) associated with each lipid  species (n  =  3).  (B) 
CTY525 (,) and CTY521 (r~) were grown in l-C- minimal me- 
dium and 20D~o0 of ceils were pulse-radiolabeled with [~4C]cho- 
line (1/zCi/ml) for the indicated periods of time. Samples were re- 
moved from the labeling culture and evaluated for total uptake of 
label into ceils while radiolabeled PLs were extracted from the re- 
mainder of the culture (see Materials and Methods). Values show 
the percentage of total label taken up by the cells which had been 
incorporated into PC in a representative experiment (determined 
as described in Materials and Methods). The magnitude of reduc- 
tion in incorporation of label into PC observed for the SEC14 over- 
producing strain relative to the isogenic wild-type strain has been 
reproduced in four independent experiments. (C) For this experi- 
ment, strains CTY525 and CTY521 were grown in methionine-free 
l-C-  medium  to  mid-log  phase  and  pulse-radiolabeled  with 
[methyl-14C] methionine for 20 rain. The percentage of total label 
taken up by the cell which had been incorporated into PC (indicated 
on y-axis) was determined as described in Materials and Methods. 
These values represent the average of three independent trials. 
reduction in the rate of PC biosynthesis via the CDP-choline 
pathway. 
Discussion 
The  PI/PC  hypothesis  for  SEC14p  function  posits  that 
SEC14p acts to maintain an appropriately elevated PI/PC ra- 
tio in Golgi membranes (Cleves et al.,  1989,  1991b).  This 
hypothesis was proposed in an attempt to reconcile: (a) the 
findings that SEC14p is required for Golgi secretory function 
in vivo and exhibits PI/PC transfer activity in vitro; and (b) 
the genetic data demonstrating that disruption of structural 
genes for enzymes of the CDP-choline pathway effects by- 
pass of the normally essential SEC14p requirement for Golgi 
secretory  function  and  yeast  cell  viability  (reviewed  in 
Cleves et al., 1991a). The PI/PC hypothesis makes one basic 
experimental prediction;  namely,  that the  PI/PC  ratio  in 
yeast Golgi membranes  will  decrease as  a  direct conse- 
quence of SEC14p dysfunction. The biochemical data re- 
ported here provide strong evidence to support the basic 
prediction of the PI/PC hypothesis, allow us to reconcile the 
puzzling issues of the inability of choline deprivation or dis- 
ruption of  EFF/to bypass SEC14p, and suggest a mechanism 
for how SEC14p stimulates Golgi secretory function in vivo. 
Highly purified yeast Golgi membranes prepared under 
SEC14p-proficient conditions exhibited a unique PL compo- 
sition;  one that was  substantially  elevated in PS,  slightly 
elevated in PI and PE, and substantially reduced in PC rela- 
tive to bulk membranes (Fig. 4 A). Thus, yeast Golgi mem- 
branes exhibited an enrichment in acidic PLs (i.e., PI and 
PS) as has also been measured for other organelle mem- 
branes of the late secretory pathway (Zinser et al.,  1991). 
Under conditions where Golgi secretory function was un- 
coupled from its usual SECI4p requirement by virtue of the 
bsd24 "bypass SEC14p" allele, imposition of SEC14p dys- 
function resulted in a nearly twofold increase in the relative 
PC content of yeast Golgi membranes (Fig. 4 D). With the 
important caveat that we do not know how bsd2-I effects by- 
pass of SEC14p, other than this bypass does not appear to 
be mediated through substantial effects on bulk membrane 
or Golgi PL composition and content (Fig. 4,  C and D), 
these data demonstrate that SEC14p functions to maintain 
the reduced PC content of wild-type Golgi membranes in 
vivo. We also noted that the PI levels of yeast Golgi mem- 
branes did not measurably vary as a function of SEC14p ac- 
tivity, suggesting that SEC14p is not involved in controlling 
PI levels in yeast Golgi membranes in vivo. This is an in- 
triguing result as PI is the preferred SEC14p ligand in the in 
vitro PL transfer reaction (Daum and Paltauf,  1984). 
Of the seven genes identified by "bypass SEC14p" muta- 
tions  (i.e.,  SACI, BSD1, BSD2,  CKI,  CPTI, BSR2,  and 
BSR3), genetic, and biochemical data identified four of  these 
to encode gene products that are required for CDP-choline 
pathway activity in vivo (Cleves et al., 1991b; Fig. 2). Inacti- 
vation of CDP-choline pathway activity by mutation of CKI, 
CPTI, BSR2, or BSR3 uniformly resulted in a significant de- 
crease in the rate of cellular PC biosynthesis, as inferred 
from  32p~ pulse-radiolabeling  experiments,  regardless  of 
whether cells were grown in I+C  ÷ or I-C- medium (Tables 
II and III). A consequence of this depression in cellular PC 
biosynthetic rate was an increase in the corresponding PI/PC 
ratios of pulse-radiolabeled bulk membrane PLs. Moreover, 
the finding that PC synthesis via the CDP-choline pathway 
made  significant contributions to  the  cellular rate of PC 
biosynthesis, even when cells were grown in choline-free 
medium,  has  profound ramifications  for the  specific or- 
ganelles that exhibit such PC biosynthetic capability. If yeast 
Golgi membranes are engaged in PC biosynthesis via the 
CDP-choline pathway,  as is the case in mammalian cells 
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membranes will experience significant net PC synthesis even 
under conditions where no net cellular PC synthesis is possi- 
ble via the CDP-choline pathway.  The idea that the yeast 
Golgi complex has such PC biosynthetic capability is sup- 
ported by our finding that mutational inactivation of the 
CDP-choline pathway prevented, in SEel4p-deficient Golgi 
membranes, the near doubling of Golgi PC content that was 
measured as a primary effect of SEC14p dysfunction (Fig. 5 
B).  On the basis of these collective data, we predict that 
mutational inactivation of the  CDP-choline pathway will 
manifest itself in a significant reduction in the relative Golgi 
membrane PC content of cells grown in I-C- medium, as 
was measured for cells cultured in the choline-replete YPD 
medium (Fig. 5 B). Unfortunately, technical difficulties as- 
sociated with purifying Golgi membranes from cells grown 
in minimal medium have precluded these very important 
measurements. Finally, in contrast to the CPT/ gene prod- 
uct, the EF//gene product did not play a significant role in 
PC biosynthesis via the CDP-choline pathway in vivo (see 
above), irrespective of  the shared ability of  both of  these gene 
products  to  efficiently catalyze the  ultimate  step  in  PC 
biosynthesis via the CDP-choline pathway in vitro (Hjelm- 
stad and Bell, 198% 1988).  This finding fully accounts for 
why cptl::LEU2 is a  "bypass SEC14p"  mutation whereas 
eptl::URA3 is not, and reinforces the genetic data that indi- 
cate SEC14p function to be tied to CDP-choline pathway ac- 
tivity in vivo (Cleves et al.,  1991b). 
How might SEC14p function interface with PC synthesis 
via the CDP-choline pathway? The genetic data demonstrat- 
ing that disruption of structural genes for CDP-choline path- 
way enzymes obviates the normally essential cellular re- 
quirement for SEC14p can be interpreted to indicate that PC 
synthesis via the CDP-choline pathway is inherently toxic 
to  Golgi secretory function and,  therefore,  cell viability. 
SEC14p would then, in principle, serve to detoxify the dele- 
terious effect of CDP-choline pathway activity in vivo. Until 
now, we have considered SEC14p function in terms of its in 
vitro PI/PC transfer activity (Cleves et al., 1991a, b). By this 
view, SEC14p could be interpreted to effect net removal of 
PC from yeast Golgi membranes via its PC transfer activity. 
This interpretation is consistent with the data indicating that 
SEC14p exhibits PL-TP activity in vitro, that SEC14p func- 
tions to maintain a reduced PC content in yeast Golgi mem- 
branes, and that SEC14p is found both as a cytosolic species 
and a peripheral Golgi membrane protein (Bankaitis et al., 
1989;  Cleves et al.,  1991b). However, the difficulties with 
this mechanism for SEC14p function are twofold: (a) it fails 
to offer an explanation for why PI is not a relevant substrate 
in vivo when PI (not PC) is the preferred SEC14p ligand in 
vitro; and (b) this model does not provide ready insight with 
respect to the relevance of the SEC14p  requirement in the 
face of CDP-choline pathway activity, but its irrelevance 
with respect to PC synthesis via the PE methylation  pathway 
(Cleves et al.,  1991b; McGee et al., 1992).  As there exists 
no in vivo evidence to indicate that any PL-TP genuinely 
functions in intraceUular PL transport per se, the in vitro PL 
transfer activity must be viewed with proper caution. In- 
deed, it is clear that SEC14p does not play an essential in 
vivo role in the retrieval, by bulk transport, of PL from the 
late stages of the secretory pathway back to the ER (Cleves 
et al.,  1991b); as had been proposed by Rothman (1990). 
Our finding that overproduction of SEC14p  resulted in a 
specific reduction in cellular PC synthesis via the CDP-cho- 
line pathway (Fig. 6), while not obviously consistent with a 
PL transfer mechanism for SEC14p  function, does suggest 
an alternative mechanism for SEC14p function in vivo; one 
that posits a sensor function for SEC14p rather than a genu- 
ine PL transfer function (i.e., the catalysis of PL transfer 
from one  membrane  to  a  second biochemically distinct 
membrane).  The  basic  features  of  a  sensor  model  for 
SEC14p function are illustrated in Fig. 7. In that model we 
consider the various genetic and biochemical data to indicate 
that SEC14p serves to repress CDP-choline activity in yeast 
Golgi  membranes.  SEC14p  is  considered  to  exist  in  a 
dynamic equilibrium between Golgi membrane-bound and 
cytosolic states, thereby allowing SEC14p to continuously 
exchange bound PL for Golgi membrane PL. As a result, a 
peripheral SEC14p  population is maintained whose bound 
PL component in effect reflects the Golgi membrane PI/PC 
content at any given time and can potentially be used as a 
signal  through  which  a  sensitive  regulation of the  local 
CDP-choline pathway activity in Golgi membranes could be 
achieved. For example, the PI- or PC-bound form of SEC14p 
could potentially serve as a specific allosteric repressor of 
Golgi PC synthesis via the CDP-choline pathway (Fig. 7). 
This  model  accounts  for  the  available  data  concerning 
SEC14p  function  in  vivo,  including  the  localization  of 
SEC14p to Golgi membranes and cytosol and the dramatic 
increase in Golgi membrane PC content by inactivation of 
SEC14p  in the face of a  functional CDP-choline pathway 
(Cleves et al., 1991b; Fig. 4 D). Moreover, this model pro- 
vides an explanation for why suppression of SEC14p  dys- 
function is effected by inactivation of the CDP-choline path- 
way but not the PE methylation pathway for PC synthesis. 
We also find the sensor model for SEC14p function in vivo 
to be attractive not only because it is consistent with the in 
vivo data, but because it reconciles a curious property of 
SECl4p-mediated PL transfer activity in vitro with SEC14p 
function in vivo. It has long been appreciated that many PL- 
TPs,  SEC14p  included,  efficiently catalyze PL exchange 
reactions in vitro but are not efficient catalysts of net PL 
transfer reactions (Daum and Paltauf,  1984;  Wirtz,  1991; 
Rueckert and Schmidt, 1991). This property is not immedi- 
ately consistent with a role for SEC14p in limited intracellu- 
lar PL transport reactions as net PL transfer by definition ac- 
complishes work whereas PL exchange need not. The sensor 
model predicts that the functional reaction mode for SEC14p 
in vivo will be simple PL exchange, not genuine PL trans- 
port, and leaves open the possibility that PI could be a rele- 
vant ligand in a Golgi PI/PC sensing reaction (Fig. 7). Thus, 
the increase in Golgi PC that directly results from SEC14p 
dysfunction is proposed to reflect loss of a local SEC14p- 
dependent downregulation  of  PC synthesis via the CDP-cho- 
line pathway and not loss of SEC14p-mediated transport of 
PC from the Golgi. However,  we must emphasize that the 
sensor model does not resolve all of the in vivo data. This 
model, in its basic form, suffers from its failure to offer a 
specific mechanism for why Golgi secretory function ex- 
hibits such a remarkable differential sensitivity to PC synthe- 
sis via each of these two PC biosynthetic pathways. 
In summary, we have obtained biochemical data that dem- 
onstrate the in vivo function of SEC14p  to be the main- 
tenance of a reduced PC content in yeast Golgi membranes; 
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The  sensor  model  proposes 
that  Golgi  membranes  have 
PC biosynthetic capability via 
the  CDP-choline  pathway, 
and that SEC14p functions to 
specifically regulate PC  syn- 
thesis  via  the  CDP-choline 
pathway as a function of the 
PI, PC, or relative PI/PC con- 
tent  of  yeast  Golgi  mem- 
branes.  SEC14p is  proposed 
to sample Golgi PI and/or PC 
composition by constantly ex- 
changing bound PL for Golgi 
membrane PL, an activity that 
would  manifest  itself  as  an 
efficient PI/PC-TP  exchange 
activity  in  vitro  and  an 
efficient  sensing reaction  in 
vivo. A specific PL-bound isoform of SEC14p could then serve to, either directly or indirectly, regulate the rate of PC biosynthesis via 
the CDP-choline pathway  in an allosteric manner. The genetic data indicating that loss of CDP-choline pathway  function results in a "bypass 
SEC14p" phenotype suggests a negative regulatory role for SEC14p in such a process (Cleves et al., 1991b). The enzymes of the CDP-cho- 
line PC biosynthetic pathway  are indicated: choline kinase (CKI), choline-phosphate cytidylyltransferase (CCT), and cholinephosphotrans- 
ferase  (CPT).  This  model  satisfactorily accounts  for the  available in  vivo data  for SEC14p function without  invoking a  genuine 
PL transfer mechanism for SEC14p activity. 
specifically a reduced contribution of PC synthesized via the 
CDP-choline pathway to the PC content of  yeast Golgi mem- 
branes.  We  also  demonstrate  that  PC  synthesis  via  the 
CDP-choline pathway is a significant contributor to the rate 
of PC biosynthesis in cells, irrespective of whether this path- 
way contributes to net cellular PC synthesis or whether it is 
relegated to a choline salvage activity that cannot contribute 
to net cellular PC synthesis. The finding that disruption of 
CDP-choline pathway function eliminates the dramatic in- 
crease in Golgi PC that is a direct result of SEC14p dysfunc- 
tion provides a biochemical basis for why mutational inacti- 
vation of the CDP-choline pathway results in bypass of the 
normally essential SEC14p requirement for Golgi secretory 
function and  cell viability.  Finally,  we describe evidence 
consistent with a  sensor mechanism for SEC14p  function 
that accounts for most of the available data in a model that 
does  not  invoke  a  genuine  PL  transfer  function  for  the 
SEC14p. This sensor model embraces a novel concept that 
may prove to be more widely applicable to PL transfer pro- 
teins that efficiently catalyze in vitro PL exchange reactions, 
but are inefficient catalysts of net PL transfer reactions. 
What are the ramifications of these data for the PI/PC hy- 
pothesis? Although the data reported here highlight reduced 
PC biosynthesis via the CDP-choline pathway as being cru- 
cial for yeast Golgi secretory function, other data suggest PI 
metabolism may also play an important role. A role for ino- 
sitol phospholipids, or their turnover, has been implicated in 
sacl-mediated bypass of SEC14p (Whitters et al.,  1993). In 
this regard, we note that PC synthesis via the CDP-choline 
pathway (but not the methylation pathway) directly consumes 
diacylglycerol, a  product of PL-turnover by the action of 
phospholipase C. Thus, the possibility must also be consid- 
ered that: (a) the various "bypass SEC14p" mutations share 
the unifying property of  elevating, or otherwise maintaining, 
Golgi diacylglycerol  levels; and (b) that the "bypass SEC14p" 
effect of CDP-choline pathway dysfunction reflects a potenti- 
ation of a diacylglycerol-mediated signal transduction event 
rather than a primary effect of PC content on Golgi secretory 
processes.  Elucidation of the mechanisms by which bsdl, 
bsd2,  and sac1  mutations suppress SEC14p defects in the 
face of a functional CDP-choline pathway should allow us 
to discriminate whether diacylglycerol regulates some es- 
sential reaction required for protein secretion from the Golgi 
complex, or whether yeast Golgi membranes specifically re- 
quire a reduced PC composition for the fulfillment of their 
essential secretory function. 
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